Caporali, R., Ravasio, R., Raimondo, P. and Salaffi, F. (2021) “Cost per responder for upadacitinib vs abatacept in patients with moderate-to-severe Rheumatoid Arthritis in Italy”, Global and Regional Health Technology Assessment, 8(1), pp. 69–79. doi: 10.33393/grhta.2021.2267.